← back to search

Christine Johnston

National Institute of Allergy and Infectious Diseases · US
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Herpesvirus Infections and Treatments, Cytomegalovirus and herpesvirus research, Virus-based gene therapy research, and COVID-19 Clinical Research Studies.
h-index
42
citations
6,642
works
197
NIH funding
primary concept
Medicine
email

Recent publications

Vaccine value profile for herpes simplex virus
Vaccine 2024cited by 12position: firstdoi
Genital Herpes Infection
Infectious Disease Clinics of North America 2023cited by 32position: lastdoi
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
npj Vaccines 2023cited by 32position: middledoi
Homologous and Heterologous Covid-19 Booster Vaccinations
New England Journal of Medicine 2022cited by 614position: middledoi
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Cell Reports Medicine 2022cited by 167position: middledoi
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
JAMA Network Open 2022cited by 91position: middledoi
Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study
PLoS Medicine 2022cited by 29position: middledoi
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
EClinicalMedicine 2021cited by 65position: firstdoi
Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators
American Journal of Reproductive Immunology 2021cited by 18position: middledoi
Implementation of a fully remote randomized clinical trial with cardiac monitoring
Communications Medicine 2021cited by 10position: middledoi
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Annals of Internal Medicine 2020cited by 93position: middledoi
Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction
The Lancet Infectious Diseases 2020cited by 36position: middledoi
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
Vaccine 2015cited by 148position: middledoi
Helicase–Primase Inhibitor Pritelivir for HSV-2 Infection
New England Journal of Medicine 2014cited by 161position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Laura H. Bachmann · Twitter (United States)2 papers (2020–2024)Anna Wald · University of Washington2 papers (2014–2015)Sinéad Delany‐Moretlwe · University of Cape Town1 papers (2024–2024)Sharon E. Frey · Griffith University1 papers (2015–2015)Shital M. Patel · Baylor College of Medicine1 papers (2015–2015)Houssein H. Ayoub · Qatar University1 papers (2022–2022)Katharine J Looker · University of Bristol1 papers (2024–2024) · 1 papers (2015–2015)Carolyn Deal · National Institute of Allergy and Infectious Diseases1 papers (2024–2024) · 1 papers (2024–2024)Kimberly Workowski · Centers for Disease Control and Prevention1 papers (2020–2020) · 1 papers (2021–2021) · 1 papers (2014–2014)Edwin L. Anderson · Boston Children's Museum1 papers (2015–2015) · 1 papers (2015–2015)Kenneth H. Fife · Indiana University School of Medicine1 papers (2014–2014)Stacy Selke · Seattle University1 papers (2014–2014)Wendy A. Keitel · Baylor College of Medicine1 papers (2015–2015) · 1 papers (2014–2014)Stephen K. Tyring · The University of Texas at Austin1 papers (2014–2014)